ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000140.1|RK-682_1 # 113 # 1258 # -1 # ID=1_1;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.729	BGC0000140.1|RK-682_1 	113	1258	-	Loose	1450	27.335	BahA	28.95	3003984	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic inactivation	Bah amidohydrolase	ATGAAGTTCCTCTTCGACGACCCCGCCTTCGACTACCAGGCCCTACGAGCCGCCGGCTACGCCGACTTCGGCGGGGCCCAGCTCGGCGAGATCATCGCCGTCGCCTCGCGCATCCCCGGCGGCGACACGGACGCCTGGCGGCGCGAGTGGACCGCGCTTGCCGAACGCGTCCACGGCCTCGCCACCGCCGCGCTCGCCCAGCACCGCACCCTCGACGCCCGCGCGGCCCTGCTGCGCGCCCACACGTACTACCGCACCGCCGAGTTCTTCCTGCGCGACGACCCGTTGCACGACCCCGAGGCGGCGCGGCTGATGCGGCTCTCCAAGGAGACCTTCGCCGAGGCGGCCGGGCTCATGGAGCGACCCCCGGAGTTCGTCCGCATCCCGTACGGGGACGGCTCGCTGCCCGGGTACTTCTACCGCGCCGACGACTCCGCCGGGCCGCGCCCGACCCTCATCCACCACGGCGGCATCGACTCCACGCTCGAAGAGGGCTACTTCTTCATCGCGGCCGCCGCCCAGGCGCGCGGCTACCACGTCCTCTGCTTCGAAGGGCCCGGGCAGGGCTCGGTGCTGCGCGAGCAGGGGCTCACCTTCCGGCCGGACTGGGAGGAGGTGGTCACGCCCGTGGTCGACTTCGCGCTGGCCCGGCCGGGGGTGGACCCCGAGCGCGTCACCCTGGTGGGGACCAGCCTCGGGGGGCTGCTCGCCGTCCGGGCCGCCGCGTTCGAGCACCGGCTCGCCGGATGCGTCGCCCATGACGCGGTCTGGCAGCTCGGGGACGTCGTCTGGCTGCCGCCGTTCGTCCACGAGTGGGTGGAGCAGGGCTGCGACGACTTCGCCAACCCGGTGATGTACGGGATCGCCGTGCAGCAGACCTTCCGCGCTGGCTGCTGCGGCAGGCGATGTGGACGTTCGGGGCGCAGAGCCCCTCCGAACTGCTGCGCCGGATGCCCGCGTTCGGCCTCGCGGACGTGGTCGGGCAGGTGCGCTGTCCGGTCCTGGTGCTCGACGCCGAGGAGGACATGTTCTTCGCCGGTCTGGAACACGCGAAGAAGGTGTACACGGGCCTGGGCGGCCCCAAGACCCTGCACGTGTTCACCGCGGACGAGGGCGGGGGAGCCCACTGCCACTCCGGCTCCATGA	MKFLFDDPAFDYQALRAAGYADFGGAQLGEIIAVASRIPGGDTDAWRREWTALAERVHGLATAALAQHRTLDARAALLRAHTYYRTAEFFLRDDPLHDPEAARLMRLSKETFAEAAGLMERPPEFVRIPYGDGSLPGYFYRADDSAGPRPTLIHHGGIDSTLEEGYFFIAAAAQARGYHVLCFEGPGQGSVLREQGLTFRPDWEEVVTPVVDFALARPGVDPERVTLVGTSLGGLLAVRAAAFEHRLAGCVAHDAVWQLGDVVWLPPFVHEWVEQGCDDFANPVMYGIAVQQTFRAGCCGRRCGRSGRRAPPNCCAGCPRSASRTWSGRCAVRSWCSTPRRTCSSPVWNTRRRCTRAWAAPRPCTCSPRTRAGEPTATPAP	MEIHKEKEKEKGVTFFRRIMANRKRRGPLSPGWKGASLGLGATGFILILIQANYLLTGHGVGKFIVGTFLFLFAAALISGLASMLLHGVKKLPSRYIWMLLYSLIMFLFCFIVQPGVSAVFIVSLAIVLSLFGALAYKFAAGSYKQVSKTRKIGAMACLSLITIAIGAGSFWLIRAGDDAAPDITLKQLKTSTRYEDSTMNNPAEQGTYPVQSLLYGSPDNYRTEFNQSGSLTTQTVDASRFVEKWSSLRTKSLGFGPEAMPLNGRVWYPEGEGTFPLVLIVHGNHLMNDYSDPGYEYLGRLLASKGYIFVSVDENFLNFSPYEDLFLISPLLSENPARGLLLLEHLQTWKDWNSDPDNPFYQKVDMERIALIGHSRGGEAVAIAAAYNKLGRHPDHGDIKFDYNFSIRSLISIAGTDGQYKPQGKPLPLQDVNYLSLHGAHDMDVNSLDGAKQYHRIRYTKGTNYMKSLVYIYGANHGQFNGGWGRGDGAGLGNQLFNLRQIMPRDEQETIAKVFISSFLDATLKDQRQYREVFKDLGYAKEWIPDNLYVGNYYDSQTTLIADFHEDIDLQSTTLPGGSLRGENLQQWKEEKVKTKWGEADYSAVRLGWNSNGSSEPASYTVTLPDNGVETGRDSSIVFSLADARKTEESGDPKELINFTITVEDRKGHQASLPLSHISKLPPVIEGKLLKWPFSNAGNTSEPVFQSYDFQLDDYYKMNPDFNPQQLSKIRIEFNLTKRGSILLRDVGIRS	50.66	gnl|BL_ORD_ID|2229|hsp_num:0	2521			864	1167	bacitracin
BGC0000140.1|RK-682_2 # 1382 # 2071 # -1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.754	BGC0000140.1|RK-682_2 	1382	2071	-	Loose	400	49.6766	MexL	29.61	3003710	protein homolog model	n/a	n/a	macrolide antibiotic; tetracycline antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCCACCACCCGTTCCACCGGAGGCCGAGGGCGCCGCGCCCACCGGCCTCCGGCCCGTCCCCGCGACCGGGGACGGGCACGCCCCCGCGCAGCGCACCGCCCGCGGCGGGCGCCAGCGCGACCCCGCGGCCGACCGGGCGATCCTGGAGAGCACCCTGGGCCTGCTGGGCGAGGGGTGCAGCTTCAGCGCGCTGTCGATGGACCTGGTGGCCCAGCGTGCCGGGGTCGCCCGCGCCACCATCTACCGCCGCTGGCGCAACAAGGAAGAGCTGGTGCTCGCGGCCCTGAGCAGCCTCGACGTGCCCGTCACCCCCTCGGACGGACTGCCCCTGCGGGAGCGTCTGGTGGATCTGGTCGACCAGATCCGCCACCGCGGCCAGGACACCCATCTGCACCGCCTGCTGGCCGGCCTCCTCGGAGAGGCGGTGCACCGGCCGCAGCTGGTGGAGGCGTACGAGAACACCGCGGTCGCCGCACGGAGGGACGCCATGCGGCAGGTGCTGCGCGACGGGCTGGACAGCGGAGAGCTGCGCCCCGGCCTCGACGTCGACCAGGCCATCGAGCTGCTCACGGGCCCGATGCTCGCGCGGCTGATCCTGCGTCAGCGGCCGGTGGAGTCCGCCGCGTTCGCCGAGGCGATCGTGGACACCTTCCTCGACGGCACCCGGAGCAACCCCGCACCCCGGTAG	MPPPVPPEAEGAAPTGLRPVPATGDGHAPAQRTARGGRQRDPAADRAILESTLGLLGEGCSFSALSMDLVAQRAGVARATIYRRWRNKEELVLAALSSLDVPVTPSDGLPLRERLVDLVDQIRHRGQDTHLHRLLAGLLGEAVHRPQLVEAYENTAVAARRDAMRQVLRDGLDSGELRPGLDVDQAIELLTGPMLARLILRQRPVESAAFAEAIVDTFLDGTRSNPAPR	MSESTSSVGPGRPKDPAKREAILEAAKRLFLCNGYDGSSMEAIASEAGVSKLTVYSHFTDKETLFSEAVKAKCAEQLPALYFQLAEGAPLEKVLLNIARGFHRLINSHEAIALTRLMAAQAGQNPKLSELFFEAGPKQVIDEMERLLEQARRSGKLAFPDARHAAEHFFMLVKGCANYRLLIGCAEPLDEAEGERHVEEVVALFLRAFAAGG	108.02	gnl|BL_ORD_ID|4690|hsp_num:0	2219			30	468	erythromycin; tetracycline; triclosan
BGC0000140.1|RK-682_3 # 2074 # 3669 # -1 # ID=1_3;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.730	BGC0000140.1|RK-682_3 	2074	3669	-	Loose	990	233.802	qacA	34.77	3003046	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGACCACTCAGCTCGAACCCCGCAAGACCGAGCAGGACCAGGCCGCCGCCCACCGCTGGTGGGTACTGGGCGTGCTCGTGGTCAGCCTCCTGCTCGTGGTCCTCGACACCTCGATCCTCAACGTCGCGCTCAAGACGCTCGCCGAGCCCGCACCGCAGGGCCTGGGCGCCTCCTCCAGCGCACTGCAGTGGTCGGTGGACTCGTACACGCTCGTCTTCGCGGCCCTCCTGTTCAGCACCGGAGTGCTGGCCGACCGCTGGGGCCGCAAACGCACGCTGGTGACCGGGCTCGTCGTCTTCGGCGGCTGCTCGCTCTGGTCCGCCTACGCGGGCAGCGCCGGCGAACTCATCGCCGCCCGCGCCGGACTCGGCGTCGGCGGGGCGCTGGTGATGCCCGCGACCCTGGCGATCATCATGAACGTCTTCCCGCCCGCCGAACACGCCAAGGCCGTCGGCATCTGGGCCGGGGCCGCAGGTCTGGCGGTCGCCGTCGGGCCCATCACCGGCGGCGCGCTCCTGGAGCACTTCTGGTGGGGCTCGGTCTTCCTCATCAACATCCCGATCGTCGTGATCGGCACCGTCGCCGCGCTGGTCGTCGTGCCGGAGTCCAGGGACCCCGGGCGCGGCGGCTTCGACCCGGTGGGCGTCGCCCTGTCCGTGGCGGGTCTGACCCTGCTCGTGTACGGGGTGATCCAGGGCGGCGAGTCGGACGACTGGGCGGCGGGGCGGGTGTGGGGGACGATGCTCGGCGGGCTCGTCGTGCTGGCGGTCTTCGTCGGTTGGGAGCGGCGGGCCGAGCGCCCGGCCCTCGACATCGCCCTGTTCCGCGTCCCGCGCTTCTCGGCCGCCGTGACCGTGATCGGCCTGGTGTTCTTCGCGCTGCTCGGCGCCACCTTCTTCCTGGTCTTCTATCTGCAGAGCGTGCGCGGCTGGACGCCCCTGCAGGCCGGGTACTGCCTGCTGCCGCTGGCCGTGGCCCAGTTGGCGTTCTCGCCGCCCGCCACGCTCGCGGCCAAGCGCATCGGGGTGCGCCCGGTGTGCACCACCGGGATGCTGCTGACCACCCTGGCGTTCGTCACCGTCGCCACCGTCGACGAGCACACCTCGCTGTGGCTGCTCGAATCCGTCTTCTTCGTCCTGGGCGTGGGCATCGCCTGTGTGATGCCGCCCGCCACCGCCGCCGTCATGTCGGCCCTGCCCCGGCAACGGGCGGGCACCGGCTCGGCCGTCAACACCACCTTCCGCCAGGTGGGCGGGGCGCTCGGCGTCGCCGTCCTCGGCTCGGTGCTCTCCACCGCCTACCGCTCGCGGATGTCGGACCACCTGGGAGCCGTGCCGGACCAACTGCGCGACAAGGCGGGGGAGTCCGTGCAGAGCAGCCTCGCCGCGGCCGACGCGCTCGGCCCGCGCGGCGCCTCTCTCGCGGGCCACGCCGTCGACTCGTTCGTCTCCGCGATGCACGTCACCGCACTGGTCGCCGCCGGGGTCACCTTCCTCGGCACCCTCGTCAGCCTGCTCCTGCTGCCCGCCCGTACGCCCGACGAAGGAGCCGGCGCGCCCGAGGCGGCCAGGGTCCACCACTCCTCGGAGGTCTGA	MTTQLEPRKTEQDQAAAHRWWVLGVLVVSLLLVVLDTSILNVALKTLAEPAPQGLGASSSALQWSVDSYTLVFAALLFSTGVLADRWGRKRTLVTGLVVFGGCSLWSAYAGSAGELIAARAGLGVGGALVMPATLAIIMNVFPPAEHAKAVGIWAGAAGLAVAVGPITGGALLEHFWWGSVFLINIPIVVIGTVAALVVVPESRDPGRGGFDPVGVALSVAGLTLLVYGVIQGGESDDWAAGRVWGTMLGGLVVLAVFVGWERRAERPALDIALFRVPRFSAAVTVIGLVFFALLGATFFLVFYLQSVRGWTPLQAGYCLLPLAVAQLAFSPPATLAAKRIGVRPVCTTGMLLTTLAFVTVATVDEHTSLWLLESVFFVLGVGIACVMPPATAAVMSALPRQRAGTGSAVNTTFRQVGGALGVAVLGSVLSTAYRSRMSDHLGAVPDQLRDKAGESVQSSLAAADALGPRGASLAGHAVDSFVSAMHVTALVAAGVTFLGTLVSLLLLPARTPDEGAGAPEAARVHHSSEV	MISFFTKTTDMMTSKKRWTALVVLAVSLFVVTMDMTILIMALPELVRELDPSGTQQLWIVDIYSLVLAGFIIPLSAFADKWGRKKALLTGFALFGLVSLAIFFAESAEFVIAIRFLLGIAGALIMPTTLSMIRVIFENPKERATALAVWSIASSIGAVFGPIIGGALLEQFSWHSAFLINVPFAIIAVVAGLFLLPESKLSKEKSHSWDIPSTILSIAGMIGLVWSIKEFSKEGLADIIPWVVIVLAITMIVIFVKRNLSSSDPMLDVRLFKKRSFSAGTIAAFMTMFAMASVLLLASQWLQVVEELSPFKAGLYLLPMAIGDMVFAPIAPGLAARFGPKIVLPSGIGIAAIGMFIMYFFGHPLSYSTMALALILVGAGMASLAVASALIMLETPTSKAGNAAAVEESMYDLGNVFGVAVLGSLSSMLYRVFLDISSFSSKGIVGDLAHVAEESVVGAVEVAKATGIKQLANEAVTSFNDAFVATALVGGIIMIIISIVVYLLIPKSLDITKQK	103.31	gnl|BL_ORD_ID|339|hsp_num:0	372			18	1515	
BGC0000140.1|RK-682_4 # 4025 # 5821 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.739	BGC0000140.1|RK-682_4 	4025	5821	+	Loose	1000	33.4982	almE	29.89	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGCACCAGACGTTGACCGAGGCCGTACGTGCCGGGGCCGAGCAGCACCCCGACCGGCTCGCGTTCGTGTACCTGCACGAGGACGGCCGGACCATGCGGCCCGAGGAGCTCACCTACGCCGAACTGGACCGCCGCGCCCGGCTGATCGCCACCCGGCTGCGCCAGGAGTCGCTGGGCGACCCGTCCCGCCCGGTGCTGCTGCTCTATCCGCCCACGCTCGACTTCGTCACCGCGTTCCTCGGCTGCTTCTACGCCGGGCGCACGGCCATCCCTGCGCCGCTGCCGGACGAGCCGGGCGAGCGCCTGGCCCGGGTCAGCGGCATCCTGCGGGACGCCTCGGTGGGCGCGGTCCTGACGCTGCCCGAGCACCGCCAAGGGCTCGCCGCCTGGCTGGCCGCCTCCGGGGAGCAGGACGTGGTGTGCCTGGCGCCCGAGGACGACGGCGAGGACCCCGCGCTGTGGTTCCCGCCGCAGGTCCGCGCCGACGACATCGCCTTCCTCCAGTACAGCTCGGGCTCCACCAGCCAGCCCAAGGGCGTCATGGTCACCCACGCCAACCTGGCCGCCAACCAGGAGGCCATCCACCACGCCATGCTCACCACGCCCGGCGTCGTCACCGGCAGCTGGCTGCCGCTCTACCACGACATGGGCCTCATCGGGATGACGCTGCACCCGCTGTGGATGGGCGGCACGAGCGTCCAGATGTCGCCGATCTCCTTCATCAAGCAGCCGCACCGCTGGCTGCGGATGATCCACGACTACCGCGTCGAGGGCACCGCCTCGCCCGACTTCGGGTACGAGCTGTGCGCCCGCCGCACCACCGACGAGCAGGCCGAGGGGCTCGACCTGTCCAGCCTGCGGGTGGCGCTCAACGGCGCCGAGCCGGTGCGCGCCGCCACCATCCGCACCTTCACCGCGCGCTTCGCCGCCCAGGGACTGCGCCCCGAGGCACTGTTCCCCTGCTACGGGCTGGCCGAGAACACCCTGCTCGCCTCGGCCGGGGACACCACCGCCCCGCACGTCGAACTCGCCGTGGACGCGCACCTCCTGGAGCAGCACGAGCTGCGGCCCGCCCGCCCCGACCGCACCTCCCGGACGCTGGTGGGCTGCGGCACACCGGCCGGCAGCGAGGTGCTCATCGTCGACCCCATGACGTGCCAGGCGCTGGCGGACGGCCAGGTCGGCGAGATCTGGCTGCGCGGCCCGTCCGTGGCGCGCGGCTACTGGAACCGCCCCGAGGCCACCGACGAGACCTTCCGCGCCGAGACCGCCGACGGCCGCAACGGCTATCTGCGCACCGGCGACCTCGGCGGACTGGTCGGCGGGGAGCTGTTCGTCACCGGCCGCATCAAGGAGATGCTCATCCACCACGGCCGCAACCTCTACCCGCAGGACATCGAGCAGGCCGTGCAGGACTCGGGGCCCGCCCTGCGGCGCGGCGGCGGGGCGGTGTTCACCGTCGGGGACGAGGAGGGCGAGCGCTCGCACGTCGTGGTGGTGCAGGAGGTCCGCCCCAACCAGCAGGGCGAGCACGACCTGCCCGCCCTCGCCGCCTCGGTCCAGACGGTGCTCAGCCGCCGGTTCCAGCTCCCCGCCGCCAGTGTGGTCCTGGTGCGCCCCGGCGCGATCCGCAAGACCACCAGCGGCAAGACACAGCGCACCCTGATGCGCCGGCTGTTCCTCGACGGCGCCCTGTCCGTACTCCACCAGCGCCTGGAGCGGCCGGTCGCGGAGCTCGTCGCCCGCCCGGCCGAGACCCCCGAGCACTCGGCTCCGCTGGCCGCCCCCGGCCGCTGA	MHQTLTEAVRAGAEQHPDRLAFVYLHEDGRTMRPEELTYAELDRRARLIATRLRQESLGDPSRPVLLLYPPTLDFVTAFLGCFYAGRTAIPAPLPDEPGERLARVSGILRDASVGAVLTLPEHRQGLAAWLAASGEQDVVCLAPEDDGEDPALWFPPQVRADDIAFLQYSSGSTSQPKGVMVTHANLAANQEAIHHAMLTTPGVVTGSWLPLYHDMGLIGMTLHPLWMGGTSVQMSPISFIKQPHRWLRMIHDYRVEGTASPDFGYELCARRTTDEQAEGLDLSSLRVALNGAEPVRAATIRTFTARFAAQGLRPEALFPCYGLAENTLLASAGDTTAPHVELAVDAHLLEQHELRPARPDRTSRTLVGCGTPAGSEVLIVDPMTCQALADGQVGEIWLRGPSVARGYWNRPEATDETFRAETADGRNGYLRTGDLGGLVGGELFVTGRIKEMLIHHGRNLYPQDIEQAVQDSGPALRRGGGAVFTVGDEEGERSHVVVVQEVRPNQQGEHDLPALAASVQTVLSRRFQLPAASVVLVRPGAIRKTTSGKTQRTLMRRLFLDGALSVLHQRLERPVAELVARPAETPEHSAPLAAPGR	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	107.55	gnl|BL_ORD_ID|4935|hsp_num:0	5928			1149	1401	colistin A; colistin B
BGC0000140.1|RK-682_5 # 5864 # 6178 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.740	BGC0000140.1|RK-682_5 	5864	6178	+	Loose	550	23.8682	R39	45.45	3003565	protein homolog model	n/a	n/a	penam	antibiotic inactivation	R39 beta-lactamase	ATGTCCATCGCCCCCGACACCCGCACCGCGATCCGCCCGCAGACCCCGGTCCTCGCCCCCGCGGACCTGGAGAAGTGGCTCATCGACCGGGTGGCCTTCCATCTGCACCGGCCCGCCCGGGAGATCGACCCGACCACCCCGCTCGCCGACTACGGCATCGACTCGGTGGCCGCCATCGGCATCTGCGGCGAGATAGAGGAGCGCCACCTGCTGGCGGTCCCGCCGACCCTCGCGTACGACTTCCCGACGGTGCGCGCGATCGCCGGGCACCTGGCGGAGCTGCTCGCCGTGGGGGACGCCGGGGCCGCCTCGTGA	MSIAPDTRTAIRPQTPVLAPADLEKWLIDRVAFHLHRPAREIDPTTPLADYGIDSVAAIGICGEIEERHLLAVPPTLAYDFPTVRAIAGHLAELLAVGDAGAAS	MLFPTARRTGFAALAALALVPAAACSGSAAPAEAEPASAEVTAEDLSGEFERLESEFDARLGVYAVDTGTGEEVFHRADERFGYASTHKAFTAALVLGQNTPEELEEVVTYTEEDLVDYSPITEQHVDTGMTLLEVADAAVRHSDNTAANLLFEELGGPEGFEEDMRELGDDVISADRIETELNEVPPGETRDTSTPRAMAGSLEAFVLGDVLEEGPRDVLTEMLLNNTTGDELIRAGVPEDWRVGDKTGGGSHGSRNDIAVVWPPEDDPIVIAVMSTREQEDAEFDNALVSGATEVVVEALAP	34.21	gnl|BL_ORD_ID|4671|hsp_num:0	332			537	633	
BGC0000140.1|RK-682_7 # 9192 # 10223 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.720	BGC0000140.1|RK-682_7 	9192	10223	+	Loose	1000	35.039	HelR	25.26	3007208	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic target protection	helicase-like RNA polymerase protection protein	ATGAGTCCGTCACCCGCCCCCGTCGCCCACCTGGTCTCGGTCGGCACCTGTCTGCCGGGGGAACCGGTGGACAACGCCACCCTGGCCAAGCTCGTCGGCGTCGACGAGCAGTGGGCCGAGATGTTCATCGGCAACGTCAGCAGGCACTTCGCCGTCGACCTGGCGACCGGCCAGGTCCGCCACTCCCTCGCGGACATCGCGGCGACCGCGGCGGACCGGGCCCTCGCGGCGGCGGGCCTGGAGGCCGTCGACATCGACTGCGTCGTCATGGGCACCGCCACCCCCGACCAGCTGATGCCCGCCACCGTCAACCTGGTGGCCGATCGCCTCGGCATCGACAACGTGCCCACCTACCAGCTCCAGTCCGGCTGCGCCGGGGCCGTCCAGGCGCTCGACGTGGCCCGCACCCTGCTCCTCGCCGGGCGCTGCTCGACGGTCCTGGTGATCGGCGGCGACGTCTGCGCCAAGCACCTGGAGACGGACTTCGACCCCGGCTCGCGCACCCCCGGCGAGCTGGTCAACTACATCCTGTTCGGCGACGGGGCGGGCGCGGCCGTGCTCAGCGCCGAGTCGTTCGGGGAGCGCGTGGAGATCCGCCAGGTCCTCAACCGCCTGGTGGGCCTGGGCAAGGCGCCCGGCCAGGTCATCGACTGGTTCGGCCTGGGCGACCGGCACAGCGACCGCATCGCGATCTCCGAGGACTACAAGGCGATCGAGGCGGCGGTGCCGGTCCTCGCCACCCAGATGTTCTGGGAGCTCATCGGCGACGTCGGCTGGACGGCCGACCAGGTGGACTATCTGCTGCCGCCCCAGCTCTCCGGCCGGATGAGCGACCGCATCTCCGACGCGATGCCCGCCCCGCTCGCCCAGCGCGTCAACGTGGTGCGCACGGTCGGCAACAACGGCAACGCCCTGCCCTTCCTCCAGCTCGCCGAACTGCTCGGCCAGTGGCAGGGCGGCGGGCGCGCGGTCACCGTCGCCGTGGAGTCCAGCAAGTGGATCAAGTCCGGCATCGCCCTGGAGCGCGCATGA	MSPSPAPVAHLVSVGTCLPGEPVDNATLAKLVGVDEQWAEMFIGNVSRHFAVDLATGQVRHSLADIAATAADRALAAAGLEAVDIDCVVMGTATPDQLMPATVNLVADRLGIDNVPTYQLQSGCAGAVQALDVARTLLLAGRCSTVLVIGGDVCAKHLETDFDPGSRTPGELVNYILFGDGAGAAVLSAESFGERVEIRQVLNRLVGLGKAPGQVIDWFGLGDRHSDRIAISEDYKAIEAAVPVLATQMFWELIGDVGWTADQVDYLLPPQLSGRMSDRISDAMPAPLAQRVNVVRTVGNNGNALPFLQLAELLGQWQGGGRAVTVAVESSKWIKSGIALERA	MRVLSSVDQLDGTSAFDLPDRLSAKTDPALIAADERHFSAIAKSLAETITELSDRLDATRKAPGGVGREAMDRDAEIHRLTGRLRTLRRFGLDLCLGRIVTADDAEPVYVGRLGLTDSTGRRLLVDWRSPAAEPFFAATHADPMGLTSRRRYRWTGGRVSDYWDEVFTADGLEEHAALDDQSAFIASLGSSRSPQMRDVLATIQADQDAIIRAGSRGTLVVDGGPGTGKTVVALHRSAHLLYADPRLGHRRGGVLFVGPHQPYLAYVADVLPSLGEEGVRTCTVRDLVAEGAGAAVERDAEVARLKSSADMVRAIEAAVRFYEEPPTQRMTVSTDWADVRLTADDWAEAFDAPEAGTPHNEAREQIWEELGSILLGKLGDEVPEEEFRRALRQDEELAGALHGAWPLLEAADLVGDLWSVPAYLRKCAPWLDREDVAKLQRADAQAWTVSDLPLLDAARQRLGDPEAARRRRRQQATVAAERARMADVIADVLAADDDGEGAVTMLRGQDLKDTLVDEAALTGVEPDLLAGPFAHIVVDEAQELSDAEWQMLLLRCPSRSFTIVGDRAQARHGFTESWEERLARVGLDRITVASLSINYRTPEEVMAEAEPAIRAALPDANVPTSVRSSGVPVLRGPVEELDTIVDEWLAANADGTACVIGAPRFRPGPRVRSLTPSLSKGLEFDLVVLVDPEDFGGGIEGAVDRYVAMTRATKQLVILTSS	47.51	gnl|BL_ORD_ID|4837|hsp_num:0	5819			1635	2151	rifampin; rifaximin; rifabutin
BGC0000140.1|RK-682_8 # 10220 # 12145 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.741	BGC0000140.1|RK-682_8 	10220	12145	+	Loose	600	26.1794	ICR-Mo	29.79	3004569	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	intrinsic colistin resistant phosphoethanolamine transferase	ATGACCACCATCACGGCAAACGCCTCTTCGGCGGGCGGCAGTTGGCAGGACCCGGAGGCGCTGCGCACCCTGCGCGACCTGTACGCGGCCGGGCGCCTGGAAGCCGAGTACCCGTCGGTACGGCCGCTGCTCGCCCGGCTCCCGGAGCGGCAGCTGCCCGCCGCGGGCCAGTTGCTCGCCCGGCTCGACCGCGACGACGTCGTCCGCCACCACGCCGACGTGCCCGTGGTGACCGTCGCCGTCACCGGCCAGTCCACCGTCGCCCCGCTGGTCGCCCCGCTCACCGCGGAGCTGGCGCGCCACGGGCTGCTGCTCGACCCGGTGGTCTCGCCGTACGGCTCGTATCTGGCGGACCTGCTCGGGCCCGGCGGCGCCGAGCAGGACCGGCGGCCCACGCTCACGCTGTGCCTGCTGGACGCGCACACCGTCTTCGAGGAGGTGCCGCTGCCCTGGCGGGTCGAGGACGTCGAGGCCGCGGCCAGGTCCCGGCTCGCGCTGATCTCCCGGGCCGTCCGCGCCCACCAGGACGGCGGGCGCGGCCCGTTGGTCCTCAACACGGTCCCGCTGCTGCACCGCCATGCCCGCCAGCTGGTGGATCTGCGCTCCCGGGCCCGGCTCGGCGTCGTCTGGCGCGAGTTCAACAGTGGGCTGCTCGCGCTCGCCGAGGAGCACCCCGGGCTGATCGTCGTCGACCTCGACCCGCTGATCGCCCAGGGGACACCGGCGTACGAGCCGCGCACGGGTCTGTACGCCAAGGCGCGCCTCGCCGAGGGACTGCTCGCGAGCTACGCCCGGGACGTCGGCCATCTCGTCACCGGGCTGCTCGGCCGGACCCGCAAGTGCCTGGTCCTCGACCTGGACGGGACGCTGTGGGGCGGGGTGCTCGGCGAGGACGGCGTGGACGGCGTCGAGCTCGGCAGCGGGTTCCGCGGCGAGGCGTTCGCCGAGTTCCAGCGCGTGGTGGCCCAGCTCGGCTCGCAGGGCGTGCTGCTCGCCGTCAGCAGCAAGAACGACGACGCCAAGGTGCGCGAGGCGCTGCGCGAGCACCCCTCGATGCTGCTGCGCGAGGACGACTTCGTCCGTGTCAACGCCAACTGGTCGGCCAAGCACGACAATCTGCGCGACATCGCGGAGCGGGTCGGGATCGGTCTGGACAGCTTCGTCTTCGTCGACGACAGCACCTTCGAGTGCGGTCTGGTCCGCGAGCAGCTGCCGCAGGTCGCGGTGGTCCGGGTCGACGAGGAGCCGGCGCTGCACCCGGCCGCGCTGCTCGCGGACGGCTGGTTCGACCTGCCGGTGCTCACCGACGAGGACCGCGAGCGGGCGGGCCGCTACCGCACCGAGGCCAGGCGCCAGGAGTTCCGCGAGGACACCGGCTCGTACCAGGACTATCTGGACGGTCTCGGCATCGAGGTCACCGTGCGCCCGCCGGAGCCCGCCGAGCTGTCCCGCGTCTCCCAACTCACCCTGCGCACCAACCAGTTCCACCTCGCCCCCGAGCGCCTCCAGCTGCCGCAGGTGCGGGAGTGGGCCGAGCGCCCGGACCGCGGTGTGCTGGCGGTCCGCGCCCGCGACCGGTTCGGCGACCACGGCCTGGTCGGCGCGGTGTTCTGGCGCCGCGACGCGGAGGACCTGCACATCGACAACTACGTGCTGAGCTGCCGGGTGTTCTCACGCGGCATCGAGAGCGCCTGCCTGGCGGCCGTCCTGGAGCACGCGGCGGCGTCCGGCGCGCACGGCGCGCTCGCCCGCCACCGGCCCACCCCGCGCAACGCCGCCTTCGCCTCCTTCTACATCGACCACGGCTTCGTCCCCACCGGCGTCGCCCCCGACGACCCCGCCACCGTCGTCTTCCGCCACGCCCTGCGCGACATCACGCCCGCCCCCGCCCATCTGCGGCTGCACACCGCCTTCGAGGAGAACTGA	MTTITANASSAGGSWQDPEALRTLRDLYAAGRLEAEYPSVRPLLARLPERQLPAAGQLLARLDRDDVVRHHADVPVVTVAVTGQSTVAPLVAPLTAELARHGLLLDPVVSPYGSYLADLLGPGGAEQDRRPTLTLCLLDAHTVFEEVPLPWRVEDVEAAARSRLALISRAVRAHQDGGRGPLVLNTVPLLHRHARQLVDLRSRARLGVVWREFNSGLLALAEEHPGLIVVDLDPLIAQGTPAYEPRTGLYAKARLAEGLLASYARDVGHLVTGLLGRTRKCLVLDLDGTLWGGVLGEDGVDGVELGSGFRGEAFAEFQRVVAQLGSQGVLLAVSSKNDDAKVREALREHPSMLLREDDFVRVNANWSAKHDNLRDIAERVGIGLDSFVFVDDSTFECGLVREQLPQVAVVRVDEEPALHPAALLADGWFDLPVLTDEDRERAGRYRTEARRQEFREDTGSYQDYLDGLGIEVTVRPPEPAELSRVSQLTLRTNQFHLAPERLQLPQVREWAERPDRGVLAVRARDRFGDHGLVGAVFWRRDAEDLHIDNYVLSCRVFSRGIESACLAAVLEHAAASGAHGALARHRPTPRNAAFASFYIDHGFVPTGVAPDDPATVVFRHALRDITPAPAHLRLHTAFEEN	MVHLDKVSNRMSVNNSRWLAWRQQGINAYVMMGIVALFLTLTANITFFDKATEVYPFAQHIGFIGSLPLVLFGVMLLVIVLLSYRYTLKAVLIFLLLTAAVTAYFTDTYGTVYDVNMLQNALQTDKAESADLFNVNFILRILLLGVLPSVWVAWQKVTFPPIKRSILQRGLTYLVSLGLVVLPILAMSKNYASFFREHKQLRSYTNPATPVYALGKLASIQLKQAQAPKTQIMHATDAVQVSNPTTRKPKLVVFVVGETARGDHVQLNGYNRTTFPQMAATAGVTNFNQVIACGTSTAYSVPCMFSYVGMKDYDVDTANYQENVLDTLHRLKVNILWRDNNSSSKGVTNRLPAADFVDYKTARNNTMCNTNPYGECRDVGMLVGLDDYVKQQANQNTLNQDTLIVLHQMGNHGPAYFKRYDKQFEKFTPVCQSNELAKCDPQSVINAFDNALLATDDFLAKTVNWLDKYDSTHQVAMLYVSDHGESLGENGIYLHGMPYKIAPKAQKHVASMFWAGKHSGIQAVPSNTELTHDAITPTLLKLFDVRAQTVQGKPLFIK	114.87	gnl|BL_ORD_ID|2714|hsp_num:0	3271			1287	1428	colistin A; colistin B
BGC0000140.1|RK-682_9 # 12148 # 12387 # 1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.708	BGC0000140.1|RK-682_9 	12148	12387	+	Loose	1200	22.3274	arnA	48.39	3002985	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGACCGCCACCGCCATCGCCGACGCCGCCGAGTTCTGCGCGCTCCTGGAGGACGAACTCGGCATCCGCCTCGCCCCCGAGGACCTGGACCGCCCCCTCGACGAAGTGGCCGAGTGGGACTCGGTCCATCTGCTGCGCCTGGTCACCGTGGTGGAGAACGTCACCGGCCGCCGCGTCCCGGTGGCCGACCTCCTGGAGGCCGTGACCTTCCAGCAGATGTACGAGGTGGTGCGCGCGTGA	MTATAIADAAEFCALLEDELGIRLAPEDLDRPLDEVAEWDSVHLLRLVTVVENVTGRRVPVADLLEAVTFQQMYEVVRA	MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHAPEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPANWVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLPLLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQKLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELGLVEGARLRGAACSPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKADPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVRYCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAGFREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREAQA	11.93	gnl|BL_ORD_ID|1513|hsp_num:0	1643			123	204	polymyxin B
BGC0000140.1|RK-682_10 # 12384 # 13187 # 1 # ID=1_10;partial=00;start_type=GTG;rbs_motif=AGxAGG/AGGxGG;rbs_spacer=5-10bp;gc_cont=0.769	BGC0000140.1|RK-682_10 	12384	13187	+	Loose	2000	25.409	Bifidobacterium adolescentis rpoB mutants conferring resistance to rifampicin	30.88	3004480	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic target alteration; antibiotic target replacement	rifamycin-resistant beta-subunit of RNA polymerase (rpoB)	GTGAGCGGCCCCGCCACGGCCGCCCCGGCGGGCTGCCTCGTCCGGGCGCCGCGCGAGGACGCGGCGCTGCGGCTGTTCTGCTTCCACCACGCGGGCGGCGGGGCGTCCTTCTACGCCCCGTGGCCCGCGCGGGTGGCGCCCGGAGTGGACGTCCTGCCGGTGCAGTTGCCCGGCCGCGAATCACGGTTCCGCGAGCGGCGGTTCCAGGACGCCGGGACCCTGGCCGAGGCCCTCGCCGACGAACTCGCCCCGTGGCTGGACCGGCCGTATGCGGTGTACGGGCACAGCATGGGCGCGCTGATCGGCTTCGCGGTGGCGGCGGCCCGGATGCGGGCGGGAGGCCGGGCGCCGCTCGCGCTGTACGTCGGCGCGTACGCGGCCCCGCACCTCACCCCGCCGCTGCCGCCGGCCGATCTGTACGGCGACGCGGACCTCGCCCGCCTCCTGGTGGACATCGGCGGGCTGCACCCGCAGTTCCTGGGCCGCGACGACTGGCTGCGCGCGCTGCTGCCCATCGTCCGGGACGACCTGCGGATCTGCGCCAGCCACCGGGAGGCGGGGCTGCCGGACCCGGACGACGCCGAGCAGCGACTGCCGCTGCACATCCGGGCGTTCGCGGGCTCGGACGACACTCTGGTGGACCCCGGCGCTGTCCACGCCTGGGAGCGGTACGCGCGCGACTTCCGACTGACCACCGTGCCGGGAGGCCACTTCTTCCCGCGCGAGGCCCCCGAGCCGTTCTTCGAGGAGCTCAACCGCTCGCTGGCCGCCCTGCTCACCGAGGCGCGGCAGGCCCCCGCGTGA	MSGPATAAPAGCLVRAPREDAALRLFCFHHAGGGASFYAPWPARVAPGVDVLPVQLPGRESRFRERRFQDAGTLAEALADELAPWLDRPYAVYGHSMGALIGFAVAAARMRAGGRAPLALYVGAYAAPHLTPPLPPADLYGDADLARLLVDIGGLHPQFLGRDDWLRALLPIVRDDLRICASHREAGLPDPDDAEQRLPLHIRAFAGSDDTLVDPGAVHAWERYARDFRLTTVPGGHFFPREAPEPFFEELNRSLAALLTEARQAPA	MAEATTNTTTIIARADQHDIDLHKASDRVNFGSIREPIDVPYLLGVQTDSFDWLIGNERWQKRVQEDLENGTNTVPHTSGLDEVFQEISPIENFAQTMSLTFSDPYFEEPRHTVQECKEKDYTYSAPLYVNAEFENGDTGEIKSQTVFMGDFPLQTPHGTFIIGGTERVIVSQLVRSPGVYFDRSQDRTSDKEVFGAKIIPSRGAWLEFEIDKRDVLGVRVDRKRKQSAIVFLMAIGMTKDEIADAFKDYPLVMDALAKETVQTQDEALTDLYRKIRPADTPTPEAGKNLLDSFYFNTKRYDLARVGRYKINRKLGLEKDVNDRSLSREDIIATIKYLVTLHAGETKFPGKRDGQDVDLRVDVDDIDHFGNRRIRQVGELIQNQLRTGLSRMERVVRERMTTQDPEAITPQSLINIRPVNATIKEFFGTSQLSQFMDQNNPLAGVTNKRRLSALGPGGLSRDRASMEVRDVHPSHFGRMCPIESPEGPNIGLIGSLATFGRINPFGFIETPYRKVVNGHVTDEVEYMTADRDAEHVIAQANQELDENGNFVKKQALARVGEEEAVDVPVSSVDYMDVSPRQMVSVGASLIPFLEHDEGHRALMGTNMQRQAVPLIESERPLVGTGAEWRAAVDSGDVILAEKPGVVTYVSADIIRTMNDDGTTSSYKLAKFQRSNQTTCYNQVPLIHDGERVEAGTVLADGPATQKGEMALGKNLLIAFMPWNGYNYEDAVIISQRLVQDDTLSSIHIEEYEIDARETKLGAEEITRDLPNVGEDAVANLDERGIIRIGAEVEAGDILVGKVTPKGETELTPEERLLRAIFGEKSREVRDTSLRVPHGETGTVIAVKEITREDAEEDGDELPNGVNQMIRVYIAQHRKITQGDKLSGRHGNKGVISRILPEEDMPFLADGTPVDIMLNPLGVPSRMNLGQVLELHLGWIAHAGWDISLDPDAEAAWKKYVPQGAEKGAPGTPVATPVFDGVRPETIKGLLSCTLPDRDGNKLVGPDGKATLFDGRTGEPFPKPISVGYMYMLKLHHLVDDKIHARSTGPYSMITQQPLGGKAQFGGQRFGEMEVWALEAYGAAYTLHEMMTTKSDDVDGRVRVYGAIVKGENLPPAGIPESFKVLLKEMQSLSLNVEVLNADGVAIDMKEEDDDPSTSSDDLGFNIGARPDAAAKEDQVAEEPEFQ	22.51	gnl|BL_ORD_ID|4719|hsp_num:0	2914			2709	2910	rifampin
BGC0000140.1|RK-682_11 # 13197 # 14048 # -1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.739	BGC0000140.1|RK-682_11 	13197	14048	-	Loose	550	41.9726	LRA-9	27.11	3002488	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	subclass B3 LRA beta-lactamase	ATGCCGACGATCGACATTCTCCTGCCCGGCTTCGCCATCGACACCGACCAGGGCTACCCCGCCTTCTGCGGCGTCTTCCTCGTCCGGGGCGCCGACGCCACCGGCCGCCCACGCACCGTCCTGGTCGACGCCGCCCACGTCGGGCGCCGCCCCCATCTGTGGGCGGCGCTCGCGGCGCACGGCCTCACCGCGGCGGACATCGACACCGTGGTGCTCACCCACGCCCACTGGGACCACGTACAGAACATCGACCTGTTCCCGCGCGCCGAACTGCTCCTCCACGGCGACGAGCGGCGCTACGCCCACGCGCCGCACTCGAACGACTGGGCGACCCCCGCCTGGACCGGCCTGCTGCTCGAACAGCTGCCGATCCGGGAGGTGGCGGACGGCGAGGAGATCCTGCCCGGCGTCCACGTCATCGCCCTGCCCGGGCACTCGCCCGGCAGCATCGGCGTCCTCGTCGACACCGACGCCGGGGTGGCCGCGATCACCGGCGACGCCCTGCACTTCGCGTACGTGGCCACCACGCGCCGCAACCCGCTGGTCTTCTGGGACGCCGAGCTCGCGGCCCGCAGCATCGACCGGGTGGTGGGGGCGGCCGATGTCATCTACCCGGGCCACGACCGCCCCTTCCGCCTCACCTCCGACGGCGCGATCGACTACCAGGAGCCGTTCGCGCTCACCGTCACCGGGCTGCGGCCCGACACCGAGGGGCTCGCCTTCGCCGACGGCTCCTCCCGCCCGCTGTGGGTCATGCCGGGCGTGGACGAGCAGCGCACGCTGTACGAGAAGAACGCGGAGGAGGCCCGGCGGCGCATGGCCGGGGTACCGCGCGTGGTGCGGCCGCGCTGA	MPTIDILLPGFAIDTDQGYPAFCGVFLVRGADATGRPRTVLVDAAHVGRRPHLWAALAAHGLTAADIDTVVLTHAHWDHVQNIDLFPRAELLLHGDERRYAHAPHSNDWATPAWTGLLLEQLPIREVADGEEILPGVHVIALPGHSPGSIGVLVDTDAGVAAITGDALHFAYVATTRRNPLVFWDAELAARSIDRVVGAADVIYPGHDRPFRLTSDGAIDYQEPFALTVTGLRPDTEGLAFADGSSRPLWVMPGVDEQRTLYEKNAEEARRRMAGVPRVVRPR	MKLRYLLAAALLMTTASAFGADAPKRLPVNITNKEWLMPFPGFKIVGNMYYVGTYDLGCYLIDTGAGLILVNTGIMGSYPLMKASIESLGFKTSDIKIITATHGHSDHVGDIALFKKDAPGATVYMSERDVESLESGGNFDYRRPAPEGRGGLVYDPIHVDVKTKPGDHIKLGNVDMTVLQAYGHTPGATSFSFQQTDAGKTYNVLIVNMNGINAGVKLLGSPHYPTIVEDFKNTIDMQATYKPDIWVSSHSGQFNLHQVYKPGDAYNPARFGDLAAYQKKIATAKANYEKQLAEERAAAK	94.02	gnl|BL_ORD_ID|100|hsp_num:0	118			117	600	
BGC0000140.1|RK-682_12 # 14100 # 14999 # -1 # ID=1_12;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.754	BGC0000140.1|RK-682_12 	14100	14999	-	Loose	1000	59.3066	almE	25.87	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	CTCATGGACGAGCACCGGGTCACCGTCTTCGGCAGCTCGCCCAGCCTGGCGCGGGCGATGATGACCACCGCCGGGCCCGGGTCCGCCGCGTCCCGGCTGCGGATCCTCGGCTCCACCGGCGAGCCCTGGACCGAGGACGCCTGGCGCTGGTACTTCCACGAGGTCGGCGGCGGCCGCTGCCCCGTCATCAACATCAGCGGCGGTACGGAGGTGGGCGGTTCGCTCCTGGCGTCCGCGCCCACCGTCCCCCAGACGCCGTGCGGCTTCACCGGACCCTGCCTCGGCATCGACGCGGTCATCGAGGACGCGGACGGCGCCGAGGTAGGCGAGGGCGAGATGGGCGAACTGGTGGTGCGCCAGTCCTGGCCGGGCATGACCCGGGGCCTGTGGCGCGCGCCGGAGCGGTTCGCCCACACCTACTTCAGCCGCAGGCCCGGCCGCTGGTCCCACGGCGACCTCGCCTCCCGGTCCGACGGGGAGTGGTTCGTGCACGGCCGCCTCGACGACGTGATGAAGGTGGCGGGCAAACGGCTCGGCCCCGCCGAGGTCGAGGAGGCCGCGCTCGGGGACCCCGCCGTGGCCGAGGCGGCGGCGGTCGGGGTGCCGCACCCGGTGAAGGGCGAGGCGCTGTGGTGCTTCGTGGTGCCCGCGCACGGGACGCTCTCCGCGCCGGAAGCCGACCGGATCCGCGCCCGCGTCGCCGACGCGCTCGGGCCCGCCTTCCGGCCCAGCCGCGTGATCGCCCTGCCCGAACTGCCCCGGACCCGCACCGGCAAGGTGATGCGCCGCCTGATGCGCGACTGCGTCACCCAGGACCCATCCGGCGACCTCTCCACGCTCGCCAACCCGCACAGCCTCGAAGCGCTGCGCGCCGCCGTCCACGAGGCGGCCGACGGCTGA	LMDEHRVTVFGSSPSLARAMMTTAGPGSAASRLRILGSTGEPWTEDAWRWYFHEVGGGRCPVINISGGTEVGGSLLASAPTVPQTPCGFTGPCLGIDAVIEDADGAEVGEGEMGELVVRQSWPGMTRGLWRAPERFAHTYFSRRPGRWSHGDLASRSDGEWFVHGRLDDVMKVAGKRLGPAEVEEAALGDPAVAEAAAVGVPHPVKGEALWCFVVPAHGTLSAPEADRIRARVADALGPAFRPSRVIALPELPRTRTGKVMRRLMRDCVTQDPSGDLSTLANPHSLEALRAAVHEAADG	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	53.78	gnl|BL_ORD_ID|4935|hsp_num:0	5928			828	1650	colistin A; colistin B
